PE20040529A1 - Medicamentos que contienen 1-demetilamino-3(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo - Google Patents
Medicamentos que contienen 1-demetilamino-3(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activoInfo
- Publication number
- PE20040529A1 PE20040529A1 PE2003000521A PE2003000521A PE20040529A1 PE 20040529 A1 PE20040529 A1 PE 20040529A1 PE 2003000521 A PE2003000521 A PE 2003000521A PE 2003000521 A PE2003000521 A PE 2003000521A PE 20040529 A1 PE20040529 A1 PE 20040529A1
- Authority
- PE
- Peru
- Prior art keywords
- pentan
- methyl
- delayed release
- demethylamine
- metoxy
- Prior art date
Links
- 230000003111 delayed effect Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 229920003086 cellulose ether Polymers 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224108A DE10224108A1 (de) | 2002-05-29 | 2002-05-29 | 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040529A1 true PE20040529A1 (es) | 2004-08-24 |
Family
ID=29557413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000521A PE20040529A1 (es) | 2002-05-29 | 2003-05-29 | Medicamentos que contienen 1-demetilamino-3(3-metoxi-fenil)-2-metil-pentan-3-ol con liberacion retardada del compuesto activo |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1507519B1 (enExample) |
| JP (1) | JP5459818B2 (enExample) |
| AR (1) | AR039900A1 (enExample) |
| AT (1) | ATE326218T1 (enExample) |
| AU (1) | AU2003238397A1 (enExample) |
| CA (1) | CA2488220C (enExample) |
| DE (2) | DE10224108A1 (enExample) |
| DK (1) | DK1507519T3 (enExample) |
| ES (1) | ES2263976T3 (enExample) |
| MY (1) | MY134311A (enExample) |
| PE (1) | PE20040529A1 (enExample) |
| PL (1) | PL218397B1 (enExample) |
| PT (1) | PT1507519E (enExample) |
| WO (1) | WO2003099267A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US5032406A (en) * | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
| US5582837A (en) * | 1992-03-25 | 1996-12-10 | Depomed, Inc. | Alkyl-substituted cellulose-based sustained-release oral drug dosage forms |
| JPH06172161A (ja) * | 1992-12-10 | 1994-06-21 | Shin Etsu Chem Co Ltd | 徐放性錠剤 |
| DE4329794C2 (de) * | 1993-09-03 | 1997-09-18 | Gruenenthal Gmbh | Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung |
| DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
| JPH1017497A (ja) * | 1996-07-02 | 1998-01-20 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
| DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
-
2002
- 2002-05-29 DE DE10224108A patent/DE10224108A1/de not_active Withdrawn
-
2003
- 2003-05-26 AU AU2003238397A patent/AU2003238397A1/en not_active Abandoned
- 2003-05-26 JP JP2004506791A patent/JP5459818B2/ja not_active Expired - Fee Related
- 2003-05-26 ES ES03732464T patent/ES2263976T3/es not_active Expired - Lifetime
- 2003-05-26 DK DK03732464T patent/DK1507519T3/da active
- 2003-05-26 AT AT03732464T patent/ATE326218T1/de not_active IP Right Cessation
- 2003-05-26 EP EP03732464A patent/EP1507519B1/de not_active Expired - Lifetime
- 2003-05-26 DE DE50303372T patent/DE50303372D1/de not_active Expired - Lifetime
- 2003-05-26 PT PT03732464T patent/PT1507519E/pt unknown
- 2003-05-26 CA CA2488220A patent/CA2488220C/en not_active Expired - Fee Related
- 2003-05-26 PL PL374186A patent/PL218397B1/pl unknown
- 2003-05-26 WO PCT/EP2003/005488 patent/WO2003099267A1/de not_active Ceased
- 2003-05-28 MY MYPI20031965A patent/MY134311A/en unknown
- 2003-05-29 PE PE2003000521A patent/PE20040529A1/es not_active Application Discontinuation
- 2003-05-29 AR ARP030101884A patent/AR039900A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005534640A (ja) | 2005-11-17 |
| AR039900A1 (es) | 2005-03-09 |
| DE10224108A1 (de) | 2004-01-29 |
| DE50303372D1 (de) | 2006-06-22 |
| CA2488220A1 (en) | 2003-12-04 |
| MY134311A (en) | 2007-12-31 |
| AU2003238397A1 (en) | 2003-12-12 |
| PT1507519E (pt) | 2006-08-31 |
| DK1507519T3 (da) | 2006-08-28 |
| ATE326218T1 (de) | 2006-06-15 |
| EP1507519B1 (de) | 2006-05-17 |
| ES2263976T3 (es) | 2006-12-16 |
| EP1507519A1 (de) | 2005-02-23 |
| CA2488220C (en) | 2011-02-01 |
| PL218397B1 (pl) | 2014-11-28 |
| PL374186A1 (en) | 2005-10-03 |
| JP5459818B2 (ja) | 2014-04-02 |
| WO2003099267A1 (de) | 2003-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0507683A8 (pt) | dose unitária de formulação farmacêutica com liberação controlada, seu processo de preparação e uso de um copolímero de poli(acrilato de etila, metacrilato de metila) neutro | |
| CR9704A (es) | Composicion farmaceutica de liberacion modificada, proceso de preparacion y metodo para emplear la misma. | |
| AR097045A2 (es) | Sistema terapéutico transdérmico | |
| SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
| AR086249A1 (es) | Composiciones de tabletas de disolucion rapida de administracion vaginal | |
| HN2000000267A (es) | Oxazolidinonas substituidas y su uso | |
| AR082024A1 (es) | Formulacion de anticuerpo contra ox40l humano | |
| BRPI0517640A (pt) | composições farmacêuticas tópicas contendo um composto antiacne e um composto antibiótico | |
| EA200970623A1 (ru) | Гель, применимый для доставки офтальмологических лекарственных средств | |
| BRPI0707612B8 (pt) | vaso lacrado e formulações líquidas contidas no mesmo | |
| EA201001244A1 (ru) | Система доставки лекарственного средства со стабилизирующим эффектом | |
| WO2020222139A9 (en) | Formulations and methods for drug instillation into the bladder and treatment of bladder ailments | |
| MX2009004692A (es) | Composicion para el tratamiento de afecciones de la piel. | |
| CY1108069T1 (el) | Φαρμακευτικη συνθεση σε μορφη υδρογελης για διαδερμικη χορηγηση δραστικων ουσιων | |
| DE602004014964D1 (de) | Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel | |
| BR0307913A (pt) | Uso de uma composição, composição farmacêutica para administração nasal, e, métodos para eliciar um efeito terapêutico, profilático e/ou diagnóstico em um mamìfero, para obter um inìcio rápido de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero e para melhorar a biodisponibilidade de um efeito terapêutico, profilático e/ou diagnóstico de uma substância ativa em um mamìfero | |
| ECSP099251A (es) | Formulaciones farmacéuticas | |
| MX2007006775A (es) | Composiciones estables de fenofibrato con esteres de acido graso. | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
| PT1275383E (pt) | Composicao farmaceutica de libertacao modificada que contem bupropion hc1 como substancia activa | |
| CA2567807A1 (en) | Activated foam | |
| UA45562U (ru) | Лекарственное средство триметазидина дигидрохлорид в форме матриксной таблетки с пролонгированным действием | |
| PE20242349A1 (es) | Composicion en espray nasal bioadhesivo, proceso de preparacion y uso | |
| DE602004000016D1 (de) | Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon | |
| BRPI0608083A2 (pt) | composição compreendendo ocaperidona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |